Renal Transplantation: Clinical Trials

24 trials for Renal Transplantation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 1 terminated, 1 withdrawn. 24 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 324Completed 22, Terminated 1, Withdrawn 1
Phase 22Completed 1, Terminated 1

Follow Renal Transplantation: new trials by email Literature Review of Renal Transplantation trials Research Report on Renal Transplantation

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation
Corticosteroid boluses Methylprednisolone, No therapeutic modification, Stop maintenance corticotherapy - Renal Transplantation
Phase 3CompletedHospices Civils de Lyon3462015-09-022025-10-01
Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation
voclosporin, tacrolimus - Renal Transplantation
Phase 3WithdrawnAurinia Pharmaceuticals Inc.2013-03-012014-01-20
12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
Everolimus, Tacrolimus, Cyclosporin A - Kidney Transplantation, Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals6122012-12-272017-05-01
Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.
everolimus, cyclosporine, Prednison (continuous steroids) - de Novo Kidney Transplant Recipients, Renal Transplantation
Phase 3CompletedNovartis3302009-04-012016-07-19
Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients
Enteric-coated mycophenolate sodium (EC-MPS), Prednisone - Renal Transplantation
Phase 3CompletedNovartis2222007-04-012011-04-21
The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates
simvastatin - Renal Transplantation
Phase 2 / Phase 3CompletedShiraz University of Medical Sciences822007-04-012008-06-09
Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.
Everolimus + Cyclosporine, Everolimus + Enteric-coated Mycophenolate Sodium (EC-MPS), Steroids - Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals302006-10-012017-03-30
Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)
Sevoflurane, Propofol - End-stage Chronic Renal Disease, Severe Acute Kidney Failure
Phase 3CompletedUniversity Hospital, Bordeaux1202006-06-012026-05-14
Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients
Enteric-coated mycophenolate sodium (EC-MPS) - Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals1282006-06-012011-03-29
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
FTY720 - Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals1402005-05-012011-11-02
Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant
Cyclosporin A, Belatacept Less Intensive Regimen (LI), Belatacept More Intensive Regimen (MI) - Renal Transplantation
Phase 3CompletedBristol-Myers Squibb5952005-02-012017-07-07
Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients
Cyclosporine, Daclizumab, Mycophenoate Mofetil - Renal Transplantation
Phase 3CompletedHoffmann-La Roche2372004-11-012016-02-19
Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients
FTY720 - Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals6842004-05-012017-02-23
Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
FTY720 - Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals6842004-04-012011-11-02
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients
Everolimus - Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals802003-11-012011-11-02
Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients
Enteric-Coated Mycophenolate Sodium (EC-MPS) - Renal Transplantation
Phase 3CompletedNovartis692003-04-012011-01-31
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
FTY720 - Renal Transplantation
Phase 3CompletedNovartis Pharmaceuticals6842003-04-012017-08-22
Cranoc Lipid Study in Renal Transplantation
Fluvastatin - Renal Transplantation
Phase 2 / Phase 3TerminatedUniversity Hospital Schleswig-Holstein2002003-04-012011-08-08
Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants
Enteric-Coated Mycophenolate Sodium (EC-MPS) - Renal Transplantation
Phase 3CompletedNovartis552003-02-012011-01-31
Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients
Sirolimus, tacrolimus, Cyclosporine A - Renal Transplantation
Phase 3CompletedWyeth is now a wholly owned subsidiary of Pfizer8302002-01-012010-05-14

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Acute Kidney Injury (1)  ·  Graft vs Host Disease (1)  ·  Ischemia (1)  ·  Kidney Failure, Chronic (1)  ·  Rejection, Psychology (1)  ·  Renal Insufficiency (1)

Broader conditions

Behavior (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Immune System Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency, Chronic (1)  ·  Social Behavior (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Cyclosporine (7)  ·  Everolimus (6)  ·  Mycophenolic Acid (5)  ·  Fingolimod Hydrochloride (4)  ·  Sirolimus (3)  ·  Tacrolimus (3)  ·  Daclizumab (2)  ·  Adrenal Cortex Hormones (1)  ·  Basiliximab (1)  ·  Fluvastatin (1)  ·  Prednisolone (1)  ·  Prednisone (1)  ·  Propofol (1)  ·  Sevoflurane (1)  ·  Simvastatin (1)

Sponsors

Novartis Pharmaceuticals (10)  ·  Novartis (4)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (2)  ·  Aurinia Pharmaceuticals Inc. (1)  ·  Bristol-Myers Squibb (1)  ·  Hoffmann-La Roche (1)  ·  Hospices Civils de Lyon (1)  ·  Shiraz University of Medical Sciences (1)  ·  University Hospital Schleswig-Holstein (1)  ·  University Hospital, Bordeaux (1)  ·  University Hospital, Lille (1)

Countries

France (8)  ·  Germany (4)  ·  Italy (2)  ·  Switzerland (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Iran (1)  ·  Norway (1)

Top investigators

Daniel Abramowicz, MD, PhD (1)  ·  Lutz Renders, MD (1)

Results publications

PMID 15949912, PMID 17565578, PMID 18360262, PMID 22143911, PMID 22300431, PMID 24831918, PMID 26888217, PMID 38993854

NIH funding

2014 (1)